Safety of intracavernous injections using an alpha-blocking agent.

@article{Buvat1989SafetyOI,
  title={Safety of intracavernous injections using an alpha-blocking agent.},
  author={Jacques Buvat and Antoine Lemaire and M. Buvat-Herbaut and Giuseppe Marcolin},
  journal={The Journal of urology},
  year={1989},
  volume={141 6},
  pages={1364-7}
}
We tested the possibility of using intracavernous injections of the alpha-blocking agent moxisylyte (6-acetoxy-thymoxy-ethyl-dimethylamine) as treatment of erectile impotence. Laboratory studies proved moxisylyte to be more active than saline (double-blind with crossover) but less active than papaverine (crossover), since it induced prolonged erection in most patients but rigid erection in only a few. However, penile vibration proved to enhance the moxisylyte effects, the combination resulting… CONTINUE READING